Neurowyzr partners Allium Healthcare to develop brain health for Active Agers

KUALA LUMPUR, Sept 29 (Bernama) -- Neurowyzr, the Singapore Deep Neuroscience and Brain Capital company with a vision to optimise population and corporate brain health and performance using neuroscience-based digital solutions, has announced a partnership with Allium Healthcare to jointly develop brain health programmes to help Active Agers screen, monitor, prevent and improve brain health.

Allium will be the first Intermediate and Long-Term care (ILTC) provider in Asia-Pacific to provide Active Ageing programmes focused on the brain, using Neurowyzr’s Digital Brain Function Screen and future brain health solutions.

For a start, Allium will provide Neurowyzr’s Digital Brain Function Screen that enables early detection of cognitive decline to its residents, day care participants, and members of the community.

The digital and gamified solution only takes 14-16 minutes to complete and can be completed on a phone or browser. Users will receive a report upon completion that Allium healthcare staff will discuss with their patient in-depth.

According to a statement, Neuroscience studies show from age 30, nearly 10 per cent of people already begin to experience a brain health problem called Mild Cognitive Impairment (MCI). The proportion increases to 25 per cent among people aged 50, and 40 per cent at 60 years. As such, the World Health Organisation and leading clinical neuroscientists have recommended brain cognitive screening for all adults as part of routine healthcare screening.

Allium will work with Neurowyzr to design therapy options for those detected to have conditions such as Mild Cognitive Decline. Neurowyzr will also work with Allium to roll out future digital neuroscience solutions such as Digital Brain Health Diagnostics and Digital Therapy.

Neurowyzr CEO, Pang Sze Yunn said: “Our partnership with Allium enables Neurowyzr to address the problem of the early cognitive decline among the population. Not only will the population be able to access affordable cognitive screening, there will be more opportunities for them to find therapy options to reverse the decline.

“We are excited to work with an innovative new partner that is committed to finding solutions to a major societal problem.”

Bernie Poh, CEO, Allium Healthcare added: “With Singapore’s increasing focus on preventative care, we are excited to leverage new technologies to help Singaporeans on their healthy ageing journeys. This partnership with Neurowyzr increases Allium’s capability to focus on brain health.”

-- BERNAMA